Additional Proxy Soliciting Materials (definitive) (defa14a)
April 18 2019 - 4:09PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule
14a-101)
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the
Registrant ☒ Filed by a Party other than the Registrant ☐
Check the appropriate box:
|
|
|
☐
|
|
Preliminary Proxy Statement
|
|
|
☐
|
|
Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
|
|
|
☐
|
|
Definitive Proxy Statement
|
|
|
☒
|
|
Definitive Additional Materials
|
|
|
☐
|
|
Soliciting Material under §
240.14a-12
|
Agios Pharmaceuticals, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
|
|
|
|
|
☒
|
|
No fee required.
|
|
|
☐
|
|
Fee computed on table below per Exchange Act Rules
14a-6(i)(1)
and
0-11.
|
|
|
|
|
|
(1)
|
|
Title of each class of securities to which transaction applies:
|
|
|
(2)
|
|
Aggregate number of securities to which transaction applies:
|
|
|
(3)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act
Rule 0-11
(set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
(4)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
(5)
|
|
Total fee paid:
|
|
|
☐
|
|
Fee paid previously with preliminary materials.
|
|
|
☐
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2)
and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|
|
|
|
|
(1)
|
|
Amount Previously Paid:
|
|
|
(2)
|
|
Form, Schedule or Registration Statement No.:
|
|
|
(3)
|
|
Filing Party:
|
|
|
(4)
|
|
Date Filed:
|
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Stockholders to be held on
May 29, 2019 for Agios Pharmaceuticals, Inc.
This communication is not a form of voting and presents only an overview of the more complete
proxy materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting. To view the proxy statement, annual report, directions to the annual
meeting and voting instructions, go to
www.proxydocs.com/AGIO
. To submit your proxy while visiting this site, you will need the 12 digit control number in the box below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy
materials can be distributed by making them available on the Internet. We have chosen to use these procedures for our Annual Meeting and need YOUR
participation.
If you want to receive a paper or e-mail copy of the proxy
materials, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this years Annual Meeting, please make this request on or before May 17, 2019.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For a Convenient Way to VIEW Proxy Materials
|
|
|
|
and
|
|
VOTE Online go to: www.proxydocs.com/AGIO
|
Proxy Materials Available to View or Receive:
Annual Report and Proxy Statement
Printed
materials may be requested by one of the following methods:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
INTERNET
www.investorelections.com/AGIO
|
|
|
|
TELEPHONE
(866) 648-8133
|
|
|
|
*E-MAIL
paper@investorelections.com
|
|
|
|
|
You must use the 12 digit control number
located in the shaded gray box below.
|
|
*
|
|
If requesting material by e-mail, please send a blank e-mail with the 12 digit control number (located below) in the
subject line. No other requests, instructions or other inquiries should be included with your e-mail requesting material.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agios Pharmaceuticals, Inc. Notice of Annual Meeting
|
|
|
|
|
Meeting Type:
|
|
Annual Meeting
|
|
|
|
|
|
|
For holders as of:
|
|
April 8, 2019
|
|
|
|
|
|
|
Date:
|
|
Wednesday, May 29, 2019
|
|
|
|
|
Time:
|
|
9:00 A.M. (Eastern Time)
|
|
|
|
|
Place:
|
|
88 Sidney Street, Cambridge, MA 02139
|
The Board of Directors Recommends a
Vote FOR each of the director nominees listed in proposal 1 and FOR proposals 2 and 3.
|
|
|
1.
|
|
To elect each of the three Class III director nominees for three-year terms expiring at the 2022 annual meeting of
stockholders.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nominees:
|
|
(01) Jacqualyn A. Fouse, Ph.D.
|
|
|
|
|
|
|
|
|
|
|
(02) David Scadden, M.D.
|
|
|
|
|
|
|
|
|
|
|
(03) David P. Schenkein, M.D.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.
|
|
To vote, on an advisory basis, to approve named executive officer compensation.
|
|
|
3.
|
|
To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the
fiscal year ending December 31, 2019.
|
|
|
|
|
Note: To consider and act upon such other business as may properly come before the meeting or any
adjournment thereof.
|
|
|
Vote In-Person Instructions:
While we encourage stockholders to vote by the means
indicated above, a stockholder is entitled to vote in person at the Annual Meeting. If you wish to vote your shares at the Annual Meeting, please register with the Inspector of Elections at the desk marked Stockholder Registration at the
entrance to receive a ballot. Proper photo ID is required. Ballots should be returned to the Inspector of Elections in order to be counted. Additionally, a stockholder who has submitted a proxy before the meeting, may revoke that proxy in person at
the Annual Meeting.
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Sep 2023 to Sep 2024